The Practitioner’s Guide to Psychoactive DrugsAlan J. Gelenberg, Ellen L. Bassuk Once again, in their new edition of a classic American handbook of clinical psycho pharmacology, Drs. Gelenberg and Bassuk and their colleagues have produced a master work of sound clinical guidelines for the use of medicines as an increasingly central component of contemporary psychiatric practice. They have recruited an outstanding panel of coauthors, but have managed to maintain a high level of consistency of quality and style throughout the many chapters on specific classes of psychiatric illnesses and their corresponding treatments. The book continues to encapsulate the clinically rele vant essentials of the pharmacology of each major class of psychotropic agents in a way that clinicians can easily grasp. Moreover, it provides sound and carefully consid ered specific guidelines to diagnosis, drug selection, and dosing and patient assessment, with particularly rich presentations on the recognition and management of adverse effects. Inclusion of chapters on pediatric and geriatric populations and on topics pertaining to substance abuse disorders and medicolegal aspects of the field are unusual in books of this kind, and so are particularly valuable. Students and trainees will appreciate the handbook's well-organized and readable style, and practicing clinicans should be satisified with its balanced consideration of older, standard treatments as well as the latest medicines and trends in clinical psychopharmacology, with glimpses into future developments. |
Contents
CONCLUSION | |
Major Psychiatric Disorders | |
INTRODUCTION | |
CAUSAL MODELS | |
GENERAL THERAPEUTIC | |
PHARMACOTHERAPY VI CONCLUSION | |
Other editions - View all
The Practitioner’s Guide to Psychoactive Drugs Alan J. Gelenberg,Ellen L. Bassuk No preview available - 2012 |
The Practitioner’s Guide to Psychoactive Drugs Alan J. Gelenberg,Ellen L. Bassuk No preview available - 1997 |
Common terms and phrases
abuse acute administered adverse agents alcohol alprazolam amphetamine andthe anticholinergic antipsychotic drugs anxiety disorder Arch Gen Psychiatry associated barbiturates behavior benzodiazepines bipolar disorder blood borderline patients bupropion buspirone carbamazepine cardiac cardiovascular chlorpromazine chronic Clin Psychiatry clinical clinician clozapine cocaine cognitive decreased develop diagnosis diazepam discontinuation disease dopamine dosage dose effectsof efficacy episodes exposure extrapyramidal fluoxetine function halflife haloperidol hepatic hypnotics hypotension Imipramine impairment increased individuals infection inhibitors inpatients insomnia inthe intoxication intravenous levels lithium longterm lorazepam maintenance major depression mania MAOIs medication metabolism metabolites methadone monitoring mood nefazodone nervosa neuroleptic ofthe opioid overdose panic disorder patientswith pharmacologic pharmacotherapy phenobarbital phenothiazines plasma pregnancy problems Psychiatry Psychopharmacol Psychopharmacology psychosis psychotherapy psychotic psychotropic reactions receptor respiratory reuptake risk schizophrenia sedation sedativehypnotics seizures serotonin serum shouldbe side effects sleep SSRIs studies suchas syndrome tardive dyskinesia thepatient therapeutic therapy tobe tolerance tothe toxicity treated treatment treatmentof tricyclic antidepressants valproate venlafaxine withdrawal symptoms